Study Identifies Potential Drug Target For Psychiatric Illness

A new study has proved that manipulating the endocannabinoid system can modulate high levels of impulsivity that causes psychiatric illnesses such a schizophrenia, bipolar disorder and substance abuse.

The study by the Spanish researchers have found that the Cannabinoid 2 receptor, which has modulating functions in the nervous system, is involved in regulating impulsive behavior.

About Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.

"Such a result proves the relevance that manipulation of the endocannabinoid system can have in modulating high levels of impulsivity present in a wide range of psychiatric and neurological illness," explained SINC Jorge Manzanares Robles, a scientist at the Alicante Neuroscience Institute and director of the study.

Carried out on mice, the study suggests the possibility of undertaking future clinical trials using drugs that selectively act on the CB2 and thus avoid the psychoactive effects deriving from receptor CB1 manipulation, whose role in impulsivity has already been proven.

However, the authors of the study remain cautious.

Bipolar Disorder-Causes-Risk Factors-Types-Symptoms-Treatment-Complications-FAQs
Bipolar Disorder is a brain disorder in which people show “mood swings”. Changes in the level of neurotransmitters in brain, and psychosocial factors are thought to be involved.

Francisco Navarrete, lead author of the study, stated that, "it is still very early to be able to put forward a reliable therapeutic tool."

The study assessed the actions of two cannabinoid drugs that stimulate and block CB2 in the mouse strain showing high levels of impulsivity. The scientists then analysed whether these drugs were capable of modulating impulsive behavior and the cerebral modifications associated with this change in behavior.

Drug Abuse Screening Test
Drug Abuse Screening Test (DAST) is a screening test to find out if you need professional help with ‘Drug Abuse’ problem. This is only an anonymous self test.

The authors concluded that CB2 receptor activity modulation reduced impulsive behavior in mice, depending on the patterns that governed the administration of each drug. Furthermore, the genetic expression levels of CB2 tended to return to normal, leaning towards strains that had little impulsivity.

The Endocannabinoid System mainly comprises two receptors (CB1 and CB2), two endogenous ligands and two metabolism enzymes. It regulates many aspects of embryonic development and is involved in many homeostatic mechanisms.

Brain Depression
Interactive section of Medindia provides information about chemistry of Brain depression

Although it was thought that CB2 only regulates immune response on a peripheral level, a study published in the Science journal in 2005 showed that it was found in the brain under normal conditions. Since then many authors have linked it to the regulation of emotional behavior and cognitive functions.

For example, the same group of Spanish researchers has contributed greatly in applying this receptor in regulating anxiety and depression. Furthermore, others studies have demonstrated how their altered role is linked to increased chances of becoming depressed or anxious or taking drugs.

Impulsivity is a personality trait characterized by behavioral actions that lack forethought or in which the subsequent consequences are not considered.

The researchers indicated that this is "a normal behavior that allows us as human beings to adapt to our surroundings under certain circumstances that require an immediate reaction."

Nonetheless, such behavior can cause a disproportionate response and lead to a pathological state.

They're a multitude of psychiatric illness that are characterized by a high level of impulsivity. One of these includes substance abuse, which is extremely problematic for society in general.

The study has been published in the British Journal of Pharmacology.

Source-ANI